MEREO BIOPHARMA GROUP PL-ADR (MREO) Forecast, Price Target & Analyst Ratings

NASDAQ:MREO • US5894921072

Current stock price

0.3268 USD
+0.01 (+3.35%)
At close:
0.3296 USD
+0 (+0.86%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MEREO BIOPHARMA GROUP PL-ADR (MREO).

Forecast Snapshot

Consensus Price Target

Price Target
$1.79
+ 446.21% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.01
Revenue Estimate
7.14M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
81.43%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$1.79
Upside
+ 446.21%
From current price of $0.33 to mean target of $1.79, Based on 14 analyst forecasts
Low
$0.51
Median
$1.53
High
$3.15

Price Target Revisions

1 Month
0.00%
3 Months
-75.00%

Price Target Summary

14 Wall Street analysts provided a forecast for the next 12 months for MREO. The average price target is 1.79 USD. This implies a price increase of 446.21% is expected in the next year compared to the current price of 0.3268.
The average price target has been revised downward by 75% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

MREO Current Analyst RatingMREO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

MREO Historical Analyst RatingsMREO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10

Analyst Ratings Consensus

ChartMill Buy Consensus
81.43%
MREO was analyzed by 14 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about MREO.
In the previous month the buy percentage consensus was at a similar level.
MREO was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-23JP MorganDowngrade Overweight -> Neutral
2026-01-16BTIGReiterate Buy -> Buy
2026-01-13NeedhamMaintains Buy -> Buy
2025-12-30JefferiesDowngrade Buy -> Hold
2025-12-29LifeSci CapitalDowngrade Outperform -> Market Perform
2025-12-29BTIGMaintains Buy -> Buy
2025-12-22NeedhamReiterate Buy -> Buy
2025-12-18BTIGReiterate Buy -> Buy
2025-08-25JP MorganMaintains Overweight -> Overweight
2025-07-10NeedhamMaintains Buy -> Buy
2025-05-13NeedhamReiterate Buy -> Buy
2025-04-09NeedhamReiterate Buy -> Buy
2025-03-27JP MorganInitiate Overweight
2025-03-26NeedhamReiterate Buy -> Buy
2025-03-18Cantor FitzgeraldReiterate Overweight -> Overweight
2025-01-13NeedhamReiterate Buy -> Buy
2024-12-24LifeSci CapitalInitiate Outperform
2024-12-06JefferiesInitiate Buy
2024-11-12NeedhamReiterate Buy -> Buy
2024-10-01Cantor FitzgeraldReiterate Overweight -> Overweight
2024-09-16Cantor FitzgeraldReiterate Overweight -> Overweight
2024-08-13NeedhamReiterate Buy -> Buy
2024-07-22Cantor FitzgeraldReiterate Overweight -> Overweight
2024-06-20Leerink PartnersMaintains Outperform -> Outperform
2024-06-13BairdInitiate Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.01
Revenue Estimate
7.14M
Revenue Q2Q
N/A
EPS Q2Q
89.80%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
-20.00%
Revenue (3 Months)
N/A
EPS (1 Month)
-400.00%
EPS (3 Months)
33.33%

Next Earnings Summary

MREO is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.01 USD and the consensus revenue estimate is 7.14M USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
MREO revenue by date.MREO revenue by date.
10M
-100.00%		500K30.501M
6,000.20%		41.088M
34.71%		40.971M
-0.28%		44.477M
8.56%		105.2M
136.53%		173.12M
64.56%		245.35M
41.72%		347.71M
41.72%
EBITDA
YoY % growth
MREO ebitda by date.MREO ebitda by date.
-27.355M
48.17%		-46.276M
-69.17%		N/A
-58.25%		-26.145M
64.30%		9.856M
137.70%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
MREO ebit by date.MREO ebit by date.
-28.416M
47.06%		-47.364M
-66.68%		-40.107M
15.32%		-28.301M
29.44%		-27.287M
3.58%		46.196M
269.30%		-44.462M
-196.25%		1.803M
104.06%		58.979M
3,171.16%		119.53M
102.67%		211.43M
76.88%
Operating Margin
MREO operating margin by date.MREO operating margin by date.
-284.16%N/A-8,021.40%-92.79%-66.41%112.75%-99.97%1.71%34.07%48.72%60.81%
EPS
YoY % growth
MREO eps by date.MREO eps by date.
N/A
38.67%		N/A
-8.58%		-0.22
-272.97%		-0.03
84.55%		-0.04
-20.01%		0.05
211.50%		-0.05
-201.35%		0.00
100.00%		0.060.12
108.48%		0.20
73.07%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.01
89.80%		-0.01
88.10%		-0.02
-70.03%		0.03
423.03%		-0.01-0.01
14.31%		-0.01
40.01%		-0.01
-131.58%
Revenue
Q2Q % growth		7.14M3.468M
593.60%		20.434MN/AN/AN/AN/A
EBITDA
Q2Q % growth		-8.16M
24.82%		-8.16M
19.96%		-8.16M
17.18%		42.84M
651.49%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-2.402M
78.17%		-7.715M
26.51%		-9.398M
6.16%		770.712K
109.19%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MREO Yearly Revenue VS EstimatesMREO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2023 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
MREO Yearly EPS VS EstimatesMREO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2031 2032 2033 0 0.2 -0.2 -0.4 -0.6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
30.19%
EPS Next 5 Year
14.87%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
325.88%
Revenue Next 5 Year
188.06%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

MEREO BIOPHARMA GROUP PL-ADR / MREO Forecast FAQ

What is the average price target for MEREO BIOPHARMA GROUP PL-ADR (MREO) stock?

14 analysts have analysed MREO and the average price target is 1.79 USD. This implies a price increase of 446.21% is expected in the next year compared to the current price of 0.3268.

Can you provide the upcoming earnings date for MEREO BIOPHARMA GROUP PL-ADR?

MEREO BIOPHARMA GROUP PL-ADR (MREO) will report earnings on 2026-05-11.

What are the consensus estimates for MREO stock next earnings?

The consensus EPS estimate for the next earnings of MEREO BIOPHARMA GROUP PL-ADR (MREO) is -0.01 USD and the consensus revenue estimate is 7.14M USD.

What is the expected long term growth rate for MREO stock?

The expected long term growth rate for MEREO BIOPHARMA GROUP PL-ADR (MREO) is 325.88%.